av/glaxosmithkline--big.svg

COM:GSK

GSK plc

  • Stock

Last Close

1,309.50

22/11 18:38

Market Cap

617.02M

Beta: -

Volume Today

7.50M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.93B
-
4.07B
3.33%
4.47B
10.04%
4.91B
9.74%
5.33B
8.57%
5.52B
3.51%
5.71B
3.53%
5.97B
4.55%
5.89B
1.37%
5.46B
7.22%
5.32B
2.61%
average payables
8.19B
-
8.14B
0.59%
8.57B
5.37%
10.58B
23.36%
16.47B
55.68%
17.50B
6.29%
14.49B
17.23%
15.39B
6.22%
16.70B
8.50%
16.91B
1.27%
16.05B
5.06%
average receivables
7.44B
-
book value per share
1.81
-
1.11
38.78%
1.32
19.39%
0.29
78.15%
-0.02
106.02%
1.11
6,475.23%
3.03
173.03%
3.66
21.01%
3.76
2.64%
2.63
30.01%
3.25
23.33%
capex per share
-0.44
-
-0.46
3.43%
-0.49
8.05%
-0.60
22.99%
-0.56
6.88%
-0.46
18.90%
-0.55
19.63%
-0.56
2.91%
-0.73
30.19%
-0.56
23.40%
-0.57
1.66%
capex to depreciation
-1.20
-
-0.86
28.10%
-1.02
18.13%
-1.26
23.79%
-0.74
41.55%
-1.02
37.91%
-0.72
29.13%
-3.59
397.00%
-1.16
67.64%
-0.98
15.38%
-0.82
16.27%
capex to operating cash flow
-0.24
-
-0.34
43.63%
-0.74
118.74%
-0.36
51.08%
-0.32
12.08%
-0.21
33.00%
-0.27
26.46%
-0.27
1.65%
-0.37
38.96%
-0.31
17.25%
-0.37
21.06%
capex to revenue
-0.06
-
-0.08
18.60%
-0.08
4.41%
-0.08
6.13%
-0.07
13.50%
-0.06
20.12%
-0.06
9.97%
-0.07
2.47%
-0.09
30.85%
-0.08
10.38%
-0.08
0.37%
cash per share
1.45
-
1.15
20.93%
1.53
33.35%
1.28
16.07%
1.00
21.98%
1.01
0.63%
1.21
20.11%
1.60
32.31%
1.08
32.32%
1.96
80.67%
1.26
35.57%
days of inventory on hand
165.81
-
210.89
27.18%
194.44
7.80%
200.46
3.10%
196.12
2.16%
195.17
0.49%
182.98
6.25%
186.99
2.19%
181.92
2.71%
196.60
8.07%
239.24
21.69%
days payables outstanding
353.61
-
396.65
12.17%
378.94
4.47%
470.06
24.05%
740.09
57.45%
500.29
32.40%
459.64
8.13%
493.98
7.47%
552.20
11.79%
621.31
12.51%
689.44
10.97%
days sales outstanding
93.37
-
debt to assets
0.43
-
0.46
6.59%
0.31
32.65%
0.32
2.20%
0.30
4.70%
0.45
48.09%
0.38
14.71%
0.34
11.82%
0.31
9.47%
0.35
14.18%
0.31
12.49%
debt to equity
2.61
-
4.41
68.98%
3.25
26.19%
16.72
414.02%
-251.31
1,603.31%
5.98
102.38%
2.55
57.41%
1.86
26.89%
1.61
13.73%
1.98
23.33%
1.35
31.83%
dividend yield
0.06
-
0.07
22.89%
0.07
0.55%
0.08
9.39%
0.08
5.34%
0.07
11.39%
0.06
16.19%
0.07
32.58%
0.06
16.47%
0.06
2.96%
0.04
37.08%
earnings yield
0.09
-
0.05
40.34%
0.16
204.80%
0.01
90.54%
0.03
97.45%
0.06
108.43%
0.07
6.75%
0.11
63.11%
0.07
36.64%
0.09
25.62%
0.08
2.78%
enterprise value
75.45B
-
67.76B
10.19%
64.26B
5.17%
75.07B
16.83%
65.30B
13.01%
81.24B
24.41%
96.72B
19.06%
74.68B
22.80%
84.68B
13.40%
75.14B
11.27%
74.70B
0.59%
enterprise value over ebitda
8.83
-
11.84
34.17%
5.22
55.90%
16.55
216.85%
9.14
44.78%
11.04
20.83%
9.55
13.51%
8.80
7.83%
9.64
9.50%
8.53
11.46%
7.94
7.00%
ev to operating cash flow
10.45
-
13.09
25.31%
25.01
91.06%
11.55
53.80%
9.44
18.30%
9.65
2.21%
12.06
25.01%
8.85
26.65%
10.65
20.38%
10.15
4.69%
11.77
15.93%
ev to sales
2.85
-
2.95
3.47%
2.69
8.81%
2.69
0.22%
2.16
19.63%
2.64
21.85%
2.87
8.71%
2.19
23.58%
2.48
13.35%
2.56
3.23%
2.46
3.88%
free cash flow per share
1.43
-
0.89
37.67%
0.17
80.59%
1.07
516.81%
1.21
13.17%
1.69
39.68%
1.48
12.18%
1.56
5.27%
1.25
19.49%
1.28
1.88%
0.97
23.79%
free cash flow yield
0.09
-
0.06
27.00%
0.01
80.55%
0.07
442.17%
0.09
33.74%
0.11
23.81%
0.08
26.39%
0.12
39.55%
0.08
32.75%
0.09
14.70%
0.07
24.45%
graham net net
-6.91
-
-7.59
9.76%
-9.39
23.77%
-11.98
27.54%
-11.82
1.34%
-12.13
2.65%
-13.54
11.57%
-12.62
6.75%
-12.62
0.00%
-9.84
22.09%
-7.90
19.72%
graham number
7.57
-
4.23
44.16%
8.05
90.55%
1.24
84.66%
0.39
68.29%
4.80
1,124.37%
8.94
86.47%
10.91
22.02%
9.63
11.76%
8.51
11.63%
9.36
9.98%
income quality
1.28
-
1.83
42.48%
0.31
83.22%
6.12
1,893.67%
3.19
47.86%
2.08
34.74%
1.52
26.85%
1.32
13.20%
1.56
18.09%
1.50
3.59%
1.29
14.37%
intangibles to total assets
0.32
-
0.30
7.55%
0.41
37.89%
0.42
2.51%
0.41
1.33%
0.40
4.17%
0.52
31.58%
0.50
3.53%
0.51
2.21%
0.36
30.85%
0.12
67.50%
interest coverage
9.16
-
4.95
46.00%
13.64
175.59%
3.53
74.11%
5.57
57.74%
6.87
23.40%
7.63
11.09%
8.73
14.32%
7.91
9.35%
7.32
7.47%
8.29
13.23%
interest debt per share
4.92
-
5.07
3.12%
4.50
11.30%
5.02
11.62%
4.56
9.21%
6.83
49.86%
7.94
16.19%
7.04
11.28%
6.23
11.49%
5.43
12.89%
4.58
15.75%
inventory turnover
2.20
-
1.73
21.37%
1.88
8.46%
1.82
3.00%
1.86
2.21%
1.87
0.49%
1.99
6.66%
1.95
2.15%
2.01
2.79%
1.86
7.47%
1.53
17.83%
invested capital
2.61
-
4.41
68.98%
3.25
26.19%
16.72
414.02%
-251.31
1,603.31%
5.98
102.38%
2.55
57.41%
1.86
26.89%
1.61
13.73%
1.98
23.33%
1.35
31.83%
market cap
62.74B
-
53.32B
15.02%
53.45B
0.26%
61.18B
14.45%
52.05B
14.92%
59.05B
13.46%
70.92B
20.10%
53.82B
24.12%
64.79B
20.38%
57.88B
10.66%
59.62B
3.01%
net current asset value
-19.05B
-
-21.04B
10.45%
-27.98B
33.01%
-37.41B
33.69%
-36.98B
1.13%
-37.47B
1.30%
-41.84B
11.68%
-39.38B
5.90%
-39.09B
0.73%
-29.28B
25.09%
-27.57B
5.86%
net debt to ebitda
1.49
-
2.53
69.79%
0.88
65.23%
3.06
248.81%
1.86
39.43%
3.02
62.57%
2.55
15.54%
2.46
3.48%
2.26
7.88%
1.96
13.43%
1.60
18.27%
net income per share
1.41
-
0.72
49.06%
2.18
204.13%
0.23
89.24%
0.39
67.09%
0.92
135.14%
1.17
27.35%
1.44
23.04%
1.10
24.15%
1.22
11.58%
1.20
1.93%
operating cash flow per share
1.87
-
1.35
27.99%
0.66
50.60%
1.67
151.39%
1.77
5.91%
2.14
21.03%
2.03
5.40%
2.12
4.63%
1.99
6.31%
1.84
7.44%
1.54
16.02%
payables turnover
1.03
-
0.92
10.85%
0.96
4.67%
0.78
19.39%
0.49
36.49%
0.73
47.93%
0.79
8.84%
0.74
6.95%
0.66
10.54%
0.59
11.12%
0.53
9.88%
receivables turnover
3.91
-
research and ddevelopement to revenue
0.15
-
0.15
1.32%
0.15
0.77%
0.13
12.58%
0.15
13.99%
0.13
14.82%
0.14
7.14%
0.15
10.47%
0.15
3.49%
0.19
20.96%
0.21
9.60%
return on tangible assets
0.19
-
0.10
49.32%
0.27
176.54%
0.03
90.03%
0.05
74.35%
0.10
123.07%
0.12
17.80%
0.14
18.09%
0.11
20.68%
0.13
11.33%
0.09
25.59%
revenue per share
6.86
-
5.98
12.79%
6.19
3.49%
7.17
15.88%
7.72
7.66%
7.84
1.52%
8.53
8.79%
8.57
0.43%
8.52
0.51%
7.28
14.53%
7.38
1.29%
roe
0.78
-
0.65
16.79%
1.65
154.74%
0.81
50.73%
-22.53
2,876.65%
0.83
103.69%
0.39
53.36%
0.39
1.68%
0.29
26.10%
0.46
59.42%
0.37
20.48%
roic
0.23
-
0.15
36.88%
0.38
153.72%
0.07
81.07%
0.15
106.64%
0.15
2.99%
0.13
11.09%
0.17
23.55%
0.14
13.34%
0.17
19.60%
0.18
6.14%
sales general and administrative to revenue
0.32
-
0.36
12.03%
0.39
7.67%
0.34
12.98%
0.32
4.59%
0.32
0.40%
0.34
5.00%
0.34
0.54%
0.32
4.24%
0.29
11.26%
shareholders equity per share
1.81
-
1.11
38.78%
1.32
19.39%
0.29
78.15%
-0.02
106.02%
1.11
6,475.23%
3.03
173.03%
3.66
21.01%
3.76
2.64%
2.63
30.01%
3.25
23.33%
stock based compensation to revenue
0.01
-
0.01
19.90%
0.02
6.59%
0.01
25.64%
0.01
3.55%
0.01
5.88%
0.01
7.42%
0.01
3.33%
0.01
3.72%
0.01
9.68%
tangible asset value
-5.68B
-
-7.11B
25.23%
-12.96B
82.27%
-19.78B
52.66%
-19.81B
0.15%
-19.32B
2.46%
-23.16B
19.88%
-19.61B
15.32%
-19.29B
1.65%
-11.27B
41.58%
5.98B
153.11%
tangible book value per share
-1.47
-
-1.85
25.83%
-3.35
81.41%
-5.09
51.74%
-5.07
0.39%
-4.91
3.02%
-5.85
19.08%
-4.93
15.81%
-4.82
2.19%
-2.80
41.92%
1.46
152.01%
working capital
1.55B
-
1.38B
10.77%
3.17B
129.21%
-2.29B
172.24%
-10.66B
365.59%
-5.56B
47.81%
-4.56B
18.06%
-1.90B
58.30%
-5.00B
162.81%
-2.04B
59.15%
-2.42B
18.77%

All numbers in (except ratios and percentages)